Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $3,753.8M | $3,207.7M | $3,000.1M | $1,752.5M | $1,842.4M | $1,911.1M | $520.7M | $2,026.9M | $2,134.9M | $2,247.2M | $2,374.3M | $3,115.7M | $3,646.0M | $3,919.0M | $4,277.3M | $4,605.0M | $4,644.4M | $5,121.6M | $4,348.6M | $4,801.2M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Encompass Health Corporation's last 12-month Revenue is $5,215.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Encompass Health Corporation's Revenue growth was 11.2%. The average annual Revenue growth rates for Encompass Health Corporation have been 3.6% over the past three years, 2.9% over the past five years.
Over the last year, Encompass Health Corporation's Revenue growth was 11.2%, which is higher than industry growth of 0.0%. It indicates that Encompass Health Corporation's Revenue growth is Good.